Hepatitis E vaccine—Illuminating the barriers to use

• Julia A. Lynch,

  Affiliation International Vaccine Institute, Seoul, Korea

  ⨯
• Jacqueline Kyungah Lim ,

  * E-mail: kajlim@gmail.com

  Affiliation International Vaccine Institute, Seoul, Korea

  https://orcid.org/0000-0001-6744-7825

  ⨯
• Philomena E. Peter Asaga,

  Affiliation International Vaccine Institute, Seoul, Korea

  ⨯
• T. Anh Wartel,

  Affiliation International Vaccine Institute, Seoul, Korea

  ⨯
• Melanie Marti,

  Affiliation Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland

  ⨯
• Beno Yakubu,

  Affiliation National Agency for Food and Drug Administration and Control (NAFDAC), Nigeria

  ⨯
• Helen Rees,

  Affiliation Wits RHI, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Kawsar Talaat,

  Affiliation Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• Brittany Kmush,

  Affiliation Department of Public Health, Syracuse University, Syracuse, New York, United States of America

  ⨯
• Rakesh Aggarwal,

  Affiliation Department of Gastroenterology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India

  ⨯
• Iza Ciglenecki,

  Affiliation Médecins sans Frontières, Geneva, Switzerland

  ⨯
• Emily Gurley,

  Affiliation Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• Alain B. Labrique

  Affiliation Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯